Although KLRG-1+ CD4 T cells showed a higher frequency in tumors compared with blood from kidney cancer patients, they displayed similar frequencies in blood and tumors from patients with the remaining cancer types (Supplementary Figure 2D). This evidence concerns the gene CD4 and cancer.